Publications by authors named "Walter Mingrone"

Claim this Profile
S
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.
Eva Kimby, Sämi Schär, Maria Cristina Pirosa, Anna Vanazzi, Ulrich M Mey, Walter Mingrone

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Stefanie Fischer, Silke Gillessen, Odile Stalder, Angelika Terbuch, Richard Cathomas, Walter Mingrone

Eur Urol Open Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines.
Mirjam Gross-Erne, Lukas Zimmerli, Stefano Bassetti, Qiyu Li, Anita Feller, Walter Mingrone

Swiss Med Wkly· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Stefanie Fischer, Christian Rothermundt, Odile Stalder, Angelika Terbuch, Thomas Hermanns, Walter Mingrone

Eur Urol Open Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Felicitas Hitz, Noémie Lang, Ulrich Mey, Walter Mingrone, Alden Moccia

Oncology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, Jörg Beyer, Emanuel Bührer, Walter Mingrone

Eur Urol Open Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
Alden A Moccia, Christian Taverna, Sämi Schär, Anna Vanazzi, Stéphanie Rondeau, Walter Mingrone

Blood Adv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule.
Jessica Rueff, Benjamin Weixler, Carsten T Viehl, Alex Ochsner, Rene Warschkow, Walter Mingrone

J Surg Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial).
Ivana Bratic Hench, Richard Cathomas, Luigi Costa, Natalie Fischer, Silke Gillessen, Walter Mingrone

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J M Mey, Walter Mingrone

Blood· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Christian Rothermundt, Claudio Thurneysen, Richard Cathomas, Beat Müller, Walter Mingrone

Swiss Med Wkly· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma.
Yannis Metaxas, Gareth Rivalland, Laetitia A Mauti, Dirk Klingbiel, Steven Kao, Walter Mingrone

J Thorac Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Christian Rothermundt, Claudio Thurneisen, Richard Cathomas, Beat Müller, Walter Mingrone

Swiss Med Wkly· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program.
Dimitrios Papazoglou, Luciano Wannesson, Dominik Berthold, Richard Cathomas, Silke Gillessen, Walter Mingrone

Clin Genitourin Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Christian Taverna, Giovanni Martinelli, Felicitas Hitz, Walter Mingrone, Thomas Pabst

J Clin Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Christoph Renner, Pier Luigi Zinzani, Rémy Gressin, Dirk Klingbiel, Pierre-Yves Dietrich, Walter Mingrone

Haematologica· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, Helmut Kranzbuehler, Roger von Moos, Walter Mingrone

J Clin Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.
Jürg Bernhard, Daniel Dietrich, Werner Scheithauer, Daniela Gerber, György Bodoky, Walter Mingrone

J Clin Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.
Dieter Koeberle, Piercarlo Saletti, Markus Borner, Daniela Gerber, Daniel Dietrich, Walter Mingrone

J Clin Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
Michael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, Max Wolf, Ruth Pettengell, Walter Mingrone

Lancet Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
Richard Herrmann, György Bodoky, Thomas Ruhstaller, Bengt Glimelius, Emilio Bajetta, Walter Mingrone

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.
Ute Gick, Christoph Rochlitz, Walter Mingrone, Bernhard Pestalozzi, Daniel Rauch

Oncology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.
Catrina Uhlmann, Pierluigi Ballabeni, Natalie Rijken, Peter Brauchli, Walter Mingrone

Oncology· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exemestane seems to stimulate tumour growth in men with prostate carcinoma.
Marco Bonomo, Walter Mingrone, Peter Brauchli, Franz Hering, Aron Goldhirsch

Eur J Cancer· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis